Abstract
Radiation therapy alone is the standard treatment for elderly patients with locally advanced non-small-cell lung cancer (NSCLC). However curative thoracic radiation therapy with concurrent chemotherapy may be feasible to selected elderly patients with NSCLC. This retrospective study was aimed to evaluate the safety and tolerability of concurrent chemoradiation therapy (CCRT) in patients aged 80 years or older.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
